The effect of Montelukast on the prevention of nasal polyp recurrence

Phase 3

Recruiting

• Conditions: Chronic rhinosinusitis.; Chronic rhinitis; J31.0

• Registration Number: IRCT20190618043934N16
• Lead Sponsor: Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 69

Inclusion Criteria

Age over 18 years
Candidate for endoscopic sinus surgery
Consent to participate in the study
Cooperation with the present research team

Exclusion Criteria

History of allergy to prescribed medication for the patient
presence of eye disease
immunodeficiency disease
allergic rhinitis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Runny nose. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient.;Headache. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient.;Nasal congestion. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient.;Sinus pain. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient.;Pain around the eyes. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient.;Pus in the nose. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient.;Cough. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient.;Decreased sense of smell Before and After Treatment. Timepoint: Runny nose before and 6 weeks after treatment. Method of measurement: By asking the patient.